CytoSorbents (CTSO) Stock Analysis: AI Score & Alternative Data
CTSO alt-data: web traffic climbing, headcount lagging
Is CytoSorbents a buy right now? The alternative data says hold. This CTSO stock analysis is built on the 25+ alternative data signals AltIndex tracks on CytoSorbents every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 53/100: a Hold. The stock trades at $6.41 with a $20M market cap.
The bullish side of the 90-day ledger: web traffic up 84.3% to 5K monthly visits, and Instagram followers up 14.0% to 367 followers. The drag: headcount (according to LinkedIn) down 7.3% to 139 employees, and just 47% of employees report a positive business outlook. That tension is what keeps the score mid-range.
CTSO’s broader alt-data profile also covers job postings (1 open roles), quarterly revenue ($10M), and X followers (911). Every signal links to its own page with full history, the CTSO technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on CTSO is just below.
CytoSorbents AI Stock Analysis
CytoSorbents (CTSO) is a critical care immunotherapy leader specializing in blood purification. The proprietary technology of CytoSorbents enables the removal of a wide variety of inflammatory mediators such as cytokines from the bloodstream, which significantly helps in various clinical conditions.
Analysis generated September 3, 2026.
Recent CytoSorbents Stock Alerts
|
CytoSorbents | September 9 Price is down by -6.1% in the last 24h. |
|
CytoSorbents | September 8 Price is up by 1834% in the last 24h. |
|
CytoSorbents | September 3 Price is down by -7.6% in the last 24h. |
|
CytoSorbents | September 2 Price is up by 6.8% in the last 24h. |
CytoSorbents Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 5K | 84.3% | |
| Job Posts | 1 | 0% | |
| LinkedIn Employees | 139 | 7.3% | |
| Employee Recommend | 65 | 0% | |
| Business Outlook | 47 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 4 | N/A | |
| Stocktwits Mentions | 8 | N/A | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 2K | 0% | |
| X Followers | 911 | 0% | |
| Instagram Followers | 367 | 14.0% |
About CytoSorbents (CTSO)
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
| Price | $6.41 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $20M |
| Year Range | $0 – $7 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Medical Devices |
Latest CytoSorbents News
View more → |
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 10 - PRNewswire |
 |
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission MeetingsSeptember 2 - PRNewswire |
 |
CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory UpdateAugust 6 - PRNewswire |
 |
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business HighlightsJuly 20 - PRNewswire |
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026June 18 - GlobeNewswire |
See CytoSorbents’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for CTSO, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREECytoSorbents Earnings & Financial Performance
View all earnings →CytoSorbents Insider Trading Activity
View all →| Chan Phillip P. filed to sell 1,744,432 shares at $0.0. Jun 15 '26 |
| MARIANI PETER J filed to sell 638,113 shares at $0.0. Jun 15 '26 |
| Chan Phillip P. filed to sell 1,734,099 shares at $0.0. Jun 12 '26 |
| MARIANI PETER J filed to sell 401,363 shares at $0.0. Dec 13 '24 |
| MARIANI PETER J filed to sell 381,363 shares at $0.0. Dec 12 '24 |
CytoSorbents Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to CytoSorbents
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Modular MedicalMODD |
$2.54 3.8% | $22M | 52 |
 |
Inspira TechnologiesIINN |
$0.38 2.1% | $17M | 42 |
 |
Adagio Medical HoldingsADGM |
$0.61 5.2% | $13M | 42 |
 |
SINTX TechnologiesSINT |
$1.80 3.2% | $12M | 54 |
 |
IridexIRIX |
$0.66 2.2% | $12M | 40 |
Explore CytoSorbents Data
Frequently Asked Questions: CytoSorbents (CTSO)
CytoSorbents has an AltIndex AI Score of 53/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
53/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of CytoSorbents (CTSO) stock is $6.41 with a market cap of $20M.
As of today, CytoSorbents’s PE (Price to Earnings) ratio is —.
View the latest CytoSorbents insider transactions to see recent buying and selling activity by company executives and directors.
Check the CytoSorbents congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The CTSO stock price chart above shows CytoSorbents’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full CytoSorbents technical analysis for RSI, moving averages, and more.
See the stocks similar to CytoSorbents section on this page for companies in the same industry ranked by market cap and AI Score.
